These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1022 related items for PubMed ID: 17942906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H.
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [Abstract] [Full Text] [Related]

  • 3. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, Leoncini L.
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.
    Nature; 2005 Jun 09; 435(7043):839-43. PubMed ID: 15944709
    [Abstract] [Full Text] [Related]

  • 9. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
    Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, Jacobs S, Poppema S, Kroesen BJ.
    Oncogene; 2007 May 31; 26(26):3769-76. PubMed ID: 17173072
    [Abstract] [Full Text] [Related]

  • 10. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
    Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG.
    J Hepatol; 2010 Jul 31; 53(1):57-66. PubMed ID: 20447714
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I, Lombard MN, Muñoz-Alonso MJ, Cañelles M, Leon J.
    Mol Carcinog; 2004 Feb 31; 39(2):85-90. PubMed ID: 14750213
    [Abstract] [Full Text] [Related]

  • 12. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.
    Genes Chromosomes Cancer; 2009 Jul 31; 48(7):615-23. PubMed ID: 19396864
    [Abstract] [Full Text] [Related]

  • 13. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sültmann H, Lyko F.
    Cancer Res; 2007 Feb 15; 67(4):1419-23. PubMed ID: 17308078
    [Abstract] [Full Text] [Related]

  • 14. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H.
    Cancer Res; 2007 Nov 01; 67(21):10117-22. PubMed ID: 17974952
    [Abstract] [Full Text] [Related]

  • 15. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME, Lemieux R, Jung D.
    J Cell Physiol; 2005 Apr 01; 203(1):277-85. PubMed ID: 15468060
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G, Carpaneto EM, Ponzanelli A, Ulivi M, Millo E, Scarfì S, Roncella S, Benatti U, Boffa LC, Ferrarini M.
    Cancer Res; 2003 Oct 01; 63(19):6144-8. PubMed ID: 14559793
    [Abstract] [Full Text] [Related]

  • 17. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J.
    Cancer Lett; 2011 Oct 01; 309(1):62-70. PubMed ID: 21664042
    [Abstract] [Full Text] [Related]

  • 18. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT.
    Cancer Res; 1993 Jan 01; 53(1):127-32. PubMed ID: 8416737
    [Abstract] [Full Text] [Related]

  • 19. c-Myc over-expression in Ramos Burkitt's lymphoma cell line predisposes to iron homeostasis disruption in vitro.
    Habel ME, Jung D.
    Biochem Biophys Res Commun; 2006 Mar 24; 341(4):1309-16. PubMed ID: 16466700
    [Abstract] [Full Text] [Related]

  • 20. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 24; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.